ADVISORY, June 02, 2016 (GLOBE NEWSWIRE) --
ITUS Corporation ("ITUS") (Nasdaq:ITUS), a company that is developing Cchek™, a platform for inexpensive and non-invasive blood tests for the early detection of cancer, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, officials from ITUS will ring the Closing Bell to commemorate National Cancer Survivors Day, which is on June 5th, and also officially launch the “Let’s Get Crack’n Against Cancer” social media campaign. The campaign asks the public to post videos to Twitter, Facebook, and Instagram, indicating why Cancer Counts™ to them, by cracking eggs marked with the word “cancer”. The purpose of the campaign is to honor people affected by cancer, and bring additional focus and a renewed sense of urgency to the ongoing cancer healthcare crisis. Additional information is available at www.ITUScorp.com and www.CancerCountsToMe.org.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Friday, June 3, 2016 – 3:45 p.m. to 4:00 p.m. ET
ITUS Media Contact:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page:
For photos from ceremonies and events, please visit our Instagram page:
For livestream of ceremonies and events, please visit our YouTube page:
For news tweets, please visit our Twitter page:
For exciting viral content and ceremony photos, please visit our Tumblr page:
A live stream of the Nasdaq Closing Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.
ITUS funds, develops, acquires, and licenses emerging technologies in areas such as Biotechnology. The Company's wholly owned subsidiary, Anixa Diagnostics Corporation, is developing a platform for non-invasive, cancer screening blood tests. Additional information is available at www.ITUScorp.com.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and nearly 17,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.